Capitalization 3.09TCr 438.24Cr 3.41TCr 37TCr P/E ratio 2024 *
-39.9x
P/E ratio 2025 * -88.4x
Enterprise value 2.99TCr 423.34Cr 3.29TCr 36TCr EV / Sales 2024 *
106x
EV / Sales 2025 * 62x
Free-Float
42.25%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-4.56%
1 week-18.37%
Current month-18.37%
1 month-33.60%
3 months+90.15%
More quotes
1 week
9.90
Extreme 9.9
12.72
1 month
9.90
Extreme 9.9
16.20
Current year
4.28
Extreme 4.28
16.20
1 year
4.28
Extreme 4.28
16.20
3 years
4.28
Extreme 4.28
16.20
5 years
4.28
Extreme 4.28
16.20
10 years
4.28
Extreme 4.28
16.20
More quotes
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-4.56%-18.37% - - 461.45Cr
-0.03%-2.26%+20.75%+2.59%23TCr
+0.24%-1.88%+23.37%-10.13%19TCr
+1.51%-1.56%+62.05%+45.25%17TCr
+1.02%+1.21%+62.52%+97.31%12TCr
-0.64%-3.54%+9.20%-7.60%6.31TCr
+10.75%+10.75%+20.27%-15.81%5.05TCr
+0.50%-1.28%+30.02%-5.10%4.13TCr
+0.02%-1.80%+32.77% - 4.11TCr
+2.46%+1.03%-9.78%-39.51%3.89TCr
Average +1.15%+0.13%+27.91%+8.38% 9.54TCr
Weighted average by Cap. +1.11%-0.63%+32.91%+16.81%
See all sector performances

Financials

2024 *2025 *
Net sales 28Cr 4.01Cr 31Cr 336.54Cr 49Cr 6.9Cr 54Cr 579.19Cr
Net income -64Cr -9.13Cr -71Cr -766.54Cr -34Cr -4.87Cr -38Cr -408.5Cr
Net Debt -105.15Cr -15Cr -115.89Cr -1.25TCr -74Cr -11Cr -82Cr -881.31Cr
More financial data * Estimated data
Logo QuantumPharm Inc.
QuantumPharm Inc is a China-based company principally engaged in the provision of drug discovery solutions and intelligent automation solutions. The Company operates its businesses through two segments. The Drug Discovery Solutions segment spans the full spectrum of the drug discovery and research process, providing modular standalone solutions to or collaborating with a diverse range of biotechnology and pharmaceutical companies and academic institutions for novel drug discovery endeavors. The Intelligent Automation Solutions segment includes solid-state research and development services and automated chemical synthesis services. Solid-state research and development services include computing services, wet laboratory services and comprehensive solutions.
Employees
760
More about the company
Date Price Change Volume
08/24/08 10.04 $ -4.56% 3,613,379
07/24/07 10.52 $ -7.07% 2,382,204
04/24/04 11.32 $ +6.99% 2,928,000
03/24/03 10.58 $ -14.26% 2,901,000
02/24/02 12.34 $ +0.33% 4,137,346

Delayed Quote Hong Kong S.E., October 08, 2024 at 01:38 pm IST

More quotes
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
10.04HKD
Average target price
7.850HKD
Spread / Average Target
-21.81%
Consensus

Annual profits - Rate of surprise